Prostate Cancer
Based on PI-RADS v2.1 combining PHI and ADC values to guide prostate biopsy in patients with PSA 4-20 ng/mL.
December 21, 2023
PIM1 drives lipid droplet accumulation to promote proliferation and survival in prostate cancer.
December 21, 2023
Phase 2 trial of a DNA vaccine (pTVG-HP) and nivolumab in patients with castration-sensitive non-metastatic (M0) prostate cancer.
December 21, 2023
Pain and its association with survival for Black and White individuals with advanced prostate cancer in the US.
December 20, 2023
Risk of Biochemical Recurrence in Patients with Grade Group 1 Prostate Cancer with Extraprostatic Extension Treated with Radical Prostatectomy.
December 20, 2023
Prostate cancer-induced endothelial-to-osteoblast transition generates an immunosuppressive bone tumor microenvironment.
December 20, 2023
Targeting glutamine dependence with DRP-104 inhibits proliferation and tumor growth of castration-resistant prostate cancer.
December 20, 2023
Impact of COVID-19 pandemic on ambulatory urologic oncology surgeries.
December 19, 2023
MRI-Guided Radiotherapy for Prostate Cancer: Seeing is Believing.
December 19, 2023
Health-related quality of life among prostate cancer survivors with metastatic disease and non-metastatic disease and men without a cancer history in the USA.
December 19, 2023